Kolling researcher recognised with prestigious award Professor Chris Little who has received a highly coveted award for his outstanding commitment to orthopaedic research. Professor Little has Research Society. “ICORS member organisations are represented across the world. They have a crucial role
dedication to orthopaedic and musculoskeletal research. Chris has a clinical and research career spanning more than three decades. He is the Director of the Raymond Purves Bone and Joint Research Lab at the Kolling Institute and a member of the Charles Perkins Centre. Chris is a qualified veterinarian with specialist surgery training. His research focuses on defining the biochemical and molecular mechanisms of joint pathology in osteoarthritis, as well as tendon and intervertebral disc degeneration.
advancing orthopaedic and musculoskeletal research by promoting basic, translational, and clinical research worldwide. “This is an important part of progressing valuable research across the globe and improving long-term health outcomes.” Chris was presented with the award by ICORS president Gun-Il Im and FIOR Chair Brian Johnstone, who thanked him for his outstanding leadership and
been elected a Fellow of International Orthopaedic Research at a key international conference in Edinburgh, Scotland. The award is only presented every three years, with around 20 people across the globe receiving the accolade. Fellows are recognised for their leadership, service, achievement and dedication to the field oforthopaedic research. Chris has welcomed the recognition, while acknowledging the support he’s received. “I am very proud to have been made a Fellow of International Orthopaedic Research,” he said. “While I have received the award, it’s actually a reflection of the wonderful work that has been done by all the researchers in my group over the years. “It is an honour to be nominated by one of the International Combined Orthopaedic Research Societies (ICORS) – and in my case, the US Orthopaedic
Professor Chris Little received top gong for outstanding commitment to orthopaedic research
Key role appointed on journey to net zero emissions by 2035 Nicola Groskops was recently appointed as NSLHD’s
such an integral role and working with a team of colleagues who share like- minded goals and aspirations for planetary health. “I feel privileged and excited to be taking on this new role,” she said. “It is fantastic to be working under Paul Klarenaar, Director Population and Planetary Health, and to be guided by Dr Kate Charlesworth, Medical Consultant Planetary Health, who is an inspiring leader in sustainability and planetary health for NSLHD and NSW
Health more broadly.” Speaking on some of the focus areas in the short term, Nicola said the district is focusing on the development of a baseline carbon footprint as well as commencing the NSLHD Net Zero Leads Program. “The development of a baseline carbon footprint for the district will allow us to better understand our carbon emissions across all hospitals and services, and monitor reductions over time,” she said.
inaugural Planetary Health Manager to help lead the district towards net zero emissions by 2035. The role involves the delivery and evaluation of the current NSLHD Planetary Health Framework 2021-2023 with the guidance of the NSLHD Planetary Health Committee, and working alongside the NSW Ministry of Health to achieve the 2035 target. Nicola said she feels privileged to be taking on
NSLHDNEWS | ISSUE 19| 7 OCTOBER 2022
6
Made with FlippingBook - professional solution for displaying marketing and sales documents online